Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis

Gut

Volumn 56, Issue 7, 2007, Pages 991-999

  Yu, Jun ^b   Hui, Alex Y ^b   Chu, Eagle S H ^b   Cheng, Alfred S L ^b   Go, Minnie Y Y ^b   Chan, Henry L Y ^b   Leung, Wai K ^b   Cheung, Kin F ^b   Ching, Arthur K K ^b   Chui, Yiu L ^b   Chan, Ka K ^b   Sung, Joseph J Y ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; KI 67 ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 2; PREALBUMIN; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL KINETICS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME IMMUNOASSAY; ENZYME INHIBITION; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE OVEREXPRESSION; HEPATITIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIVER HISTOLOGY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CHEMOKINES; CHEMOTAXIS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYTOKINES; DINOPROSTONE; FEMALE; GENE EXPRESSION; GROWTH SUBSTANCES; HEPATITIS, ANIMAL; HEPATOCYTES; IMMUNOENZYME TECHNIQUES; LIVER; LYMPHOCYTES; MACROPHAGES; MICE; MICE, TRANSGENIC; NF-KAPPA B; PYRAZOLES; SULFONAMIDES;

EID: 34347224048     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.097923     Document Type: Article

References (50)

1. Williams CS, DuBois RN. Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol 1996;270:G393-400.
2. Arslan A, Zingg HH. Regulation of COX-2 gene expression in rat uterus in vivo and in vitro. Prostaglandins 1996;52:463-81.
3. Tanaka Y, Takahashi M, Kawaguchi M, et al. Delayed release of prostaglandins from arachidonic acid and kinetic changes in prostaglandin H synthase activity on the induction of prostaglandin H synthase-2 after lipopolysaccharide-treatment of RAW264.7 macrophage-like cells. Biol Pharm Bull 1997;20:322-6.
4. Seibert K, Zhang Y, Leahy K, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 1994;91:12013-17.
5. Sanchez T, Moreno JJ. Role of leukocyte influx in tissue prostaglandin H synthase-2 overexpression induced by phorbol ester and arachidonic acid in skin. Biochem Pharmacol 1999;58:877-9.
6. Cheng AS, Chan HL, Leung NW, et al. Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy. Aliment Pharmacol Ther 2002;16:251-60.
7. Cheng AS, Chan HL, Leung WK, et al. Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2. Mod Pathol 2004;17:1169-79.
8. Yu J, Qiao L, Zimmermann L, et al. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo. Hepatology 2006;43:134-43.
9. Yu J, Ip E, Dela Pena A, et al. COX-2 induction in mice with experimental nutritional steatohepatitis: role as pro-inflammatory mediator. Hepatology 2006;43:826-36.
10. Yan C, Costa RH, Darnell JE Jr, et al. Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice. EMBO J 1990;9:869-78.
11. You X, Pan M, Gao W, et al. Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response. Arthritis Rheum 2006;54:877-86.
12. Hui AY, Leung WK, Chan HL, et al. Effect of celecoxib on experimental liver fibrosis in rat. Liver Int 2006;26:125-36.
13. Treffkorn L, Scheibe R, Maruyama T, et al. PGE2 exerts its effect on the LPS-induced release of TNF-alpha, ET-1, IL-1alpha, IL-6 and IL-10 via the EP2 and EP4 receptor in rat liver macrophages. Prostagland Other Lipid Mediat 2004;74:113-23.
14. Oshima H, Oshima M, Inaba K, et al. Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J 2004;23:1669-78.
15. Harris SG, Padilla J, Koumas L, et al. Prostaglandins as modulators of immunity. Trends Immunol 2002;23:144-50.
16. Hinson RM, Williams JA, Shacter E. Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proc Natl Acad Sci USA 1996;93:4885-90.
17. Kalinski P, Hilkens CM, Snijders A, et al. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 1997;159:28-35.
18. Hashimoto N, Watanabe T, Ikeda Y, et al. Prostaglandins induce proliferation of rat hepatocytes through a prostaglandin E2 receptor EP3 subtype. Am J Physiol 1997;272:G597-604.
19. Langenboch R, Loftin CD, Lee C, et al. Cyclooxygenase- deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis. Ann NY Acad Sci 1999;889:52-61.
20. Dela Pena A, Leclercq I, Field J, et al. NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 2005;129:1663-74.
21. Karin M, Yamamoto Y, Wang QM. The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 2004;3:17-26.
22. Appleby SB, Ristimaki A, Neilson K, et al. Structure of the human cyclooxygenase-2 gene. Biochem J 1994;302:723-7.
23. Newton R, Kuitert LM, Bergmann M, et al. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem Biophys Res Commun 1997;237:28-32.
24. Pikarsky E, Porat RM, Stein I, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004;431:461-6.
25. McClain CJ, Barve S, Deaciuc I, et al. Cytokines in alcoholic liver disease. Semin Liver Dis 1999;19:205-19.
26. Kershenobich Stalnikowitz D, Weissbrod AB. Liver fibrosis and inflammation. A review. Ann Hepatol 2003;2:159-63.
27. Gantner F, Leist M, Jilg S, et al. Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice. Gastroenterology 1995;109:166-76.
28. Gantner F, Leist M, Lohse AW, et al. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995;21:190-8.
29. Leist M, Gantner F, Bohlinger I, et al. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995;146:1220-34.
30. Jaeschke H, Farhood A, Smith CW. Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am J Physiol 1991;261:G1051-6.
31. Dinarello CA. Biology of interleukin 1. FASEB J 1988;2:108-15.
32. Mori K, Kobayashi S, Inobe M, et al. In vivo cytokine gene expression in various T cell subsets of the autoimmune MRL/Mp-Ipr/Ipr mouse. Autoimmunity 1994;17:49-57.
33. Koerner TJ, Adams DO, Hamilton TA. Regulation of tumor necrosis factor (TNF) expression: interferon-gamma enhances the accumulation of mRNA for TNF induced by lipopolysaccharide in murine peritoneal macrophages. Cell Immunol 1987;109:437-43.
34. Collart MA, Belin D, Vassalli JD, et al. Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J Exp Med 1986;164:2113-18.
35. Strassmann G, Patil-Koota V, Finkelman F, et al. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J Exp Med 1994;180:2365-70.
36. Lentsch AB, Shanley TP, SarmaV, et al. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. J Clin Invest 1997;100:2443-8.
37. Kovacs EJ. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 1991;12:17-23.
38. Walpen S, Beck KF, Schaefer L, et al. Nitric oxide induces MIP-2 transcription in rat renal mesangial cells and in a rat model of glomerulonephritis. FASEB J 2001;15:571-3.
39. Zaiss AK, Liu Q, Bowen GP, et al. Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J Virol 2002;76:4580-90.
40. Saito JM, Maher JJ. Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant. Gastroenterology 2000;118:1157-68.
41. Mizuhara H, Uno M, Seki N, et al. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 1996;23:1608-15.
42. Streetz K, Leifeld L, Grundmann D, et al. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 2000;119:446-60.
43. Tagawa Y, Kakuta S, Iwakura Y. Involvement of Fas/Fas ligand system-mediated apoptosis in the development of concanavalin A-induced hepatitis. Eur J Immunol 1998;28:4105-13.
44. Mohseni H, Zaslau S, McFadden D, et al. COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro. J Surg Res 2004;119:138-42.
45. Pentland AP, Needleman P. Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis. J Clin Invest 1986;77:246-51.
46. Gu D, Sarvetnick N. Epithelial cell proliferation and islet neogenesis in IFN-γ transgenic mice. Development 1993;118:33-46.
47. Badawi AF. The role of prostaglandin synthesis in prostate cancer. BJU Int 2000;85:451-62.
48. Faouzi S, Burckhardt BE, Hanson JC, et al. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway. J Biol Chem 2001;276:49077-82.
49. Milich DR, Wolf SF, Hughes JL, et al. Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis Be antigen transgenic mice. Proc Natl Acad Sci USA 1995;92:6847-51.
50. Kimura K, Moriwaki H, Nagaki M, et al. Pathogenic role of B cells in anti-CD40-induced necroinflammatory liver disease. Am J Pathol 2006;168:786-95.